Stimulation of protein kinase C-α suppresses colon cancer cell proliferation by down-regulation of β-catenin

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 8 B, 2009, Pages 2171-2180

  Gwak, Jungsug ^a   Jung, Soo Jin ^b   Kang, Dong Ii ^b   Kim, Eun Young ^b   Kim, Dong Eun ^c   Chung, Young Hwa ^d   Shin, Jae Gook ^a,b   Oh, Sangtaek ^a  

^a Inje University   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c Konkuk University   (South Korea)

^d Pusan National University   (South Korea)

Author keywords

Colon cancer; Degradation; Phosphorylation; Protein kinase C ; catenin

Indexed keywords

EID: 72949112245     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00683.x     Document Type: Article

References (41)

1. Parker SL, Tong T, Bolden S, et al. Cancer statistics, 1997. CA Cancer J Clin. 1997 47 : 5 27.
2. de Lau W, Barker N, Clevers H. WNT signaling in the normal intestine and colorectal cancer. Front Biosci. 2007 12 : 471 491.
3. Bienz M, Clevers H. Linking colorectal cancer to Wnt signaling. Cell. 2000 103 : 311 320.
4. Sakanoue Y, Hatada T, Kusunoki M, et al. Protein kinase C activity as marker for colorectal cancer. Int J Cancer. 1991 48 : 803 806.
5. Goldstein DR, Cacace AM, Weinstein IB. Overexpression of protein kinase C β 1 in the SW480 colon cancer cell line causes growth suppression. Carcinogenesis. 1995 16 : 1121 1126.
6. Kahl-Rainer P, Sedivy R, Marian B. Protein kinase C tissue localization in human colonic tumors suggests a role for adenoma growth control. Gastroenterology. 1996 110 : 1753 1759.
7. Kopp R, Noelke B, Sauter G, et al. Altered protein kinase C activity in biopsies of human colonic adenomas and carcinomas. Cancer Res. 1991 51 : 205 210.
8. Perletti GP, Marras E, Concari P, et al. PKCδ acts as a growth and tumor suppressor in rat colonic epithelial cells. Oncogene. 1999 18 : 1251 1256.
9. Klein IK, Ritland SR, Burgart LJ, et al. Adenoma-specific alterations of protein kinase C isozyme expression in Apc(MIN) mice. Cancer Res. 2000 60 : 2077 2080.
10. Frey MR, Clark JA, Leontieva O, et al. Protein kinase C signaling mediates a program of cell cycle withdrawal in the intestinal epithelium. J Cell Biol. 2000 151 : 763 778.
11. Jiang YH, Aukema HM, Davidson LA, et al. Localization of protein kinase C isozymes in rat colon. Cell Growth Differ. 1995 6 : 1381 1386.
12. Saxon ML, Zhao X, Black JD. Activation of protein kinase C isozymes is associated with post-mitotic events in intestinal epithelial cells in situ. J Cell Biol. 1994 126 : 747 763.
13. 2+ pathway: biochemical mediators, tools and future requirements. Front Biosci. 2004 9 : 967 974.
14. Topol L, Jiang X, Choi H, et al. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent β-catenin degradation. J Cell Biol. 2003 162 : 899 908.
15. Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta. 2003 1653 : 1 24.
16. Polakis P. Wnt signaling and cancer. Genes Dev. 2000 14 : 1837 1851.
17. Liu C, Li Y, Semenov M, et al. Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell. 2002 108 : 837 847.
18. Dominguez I, Green JB. Dorsal downregulation of GSK3β by a non-Wnt-like mechanism is an early molecular consequence of cortical rotation in early Xenopus embryos. Development. 2000 127 : 861 868.
19. Bienz M, Clevers H. Linking colorectal cancer to Wnt signaling. Cell. 2000 103 : 311 320.
20. Akiyama T. Wnt/β-catenin signaling. Cytokine Growth Factor Rev. 2000 11 : 273 282.
21. Fearnhead NS, Britton MP, Bodmer WF. The ABC of APC. Hum Mol Genet. 2001 10 : 721 733.
22. Morin PJ. β -catenin signaling and cancer. Bioessays. 1999 21 : 1021 1030.
23. Tetsu O, McCormick F. β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999 398 : 422 426.
24. He TC, Sparks AB, Rago C, et al. Identification of c-MYC as a target of the APC pathway. Science. 1998 281 : 1509 1512.
25. Takahashi M, Tsunoda T, Seiki M, et al. Identification of membrane-type matrix metalloproteinase-7 as a target of the β-catenin/TCF-4 complex in human colorectal cancers. Oncogene. 2002 21 : 5861 5867.
26. He TC, Chan TA, Vogelstein B, et al. PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell. 1999 99 : 335 345.
27. Chen YW, Lang ML, Wade WF. Protein kinase C-α and -γ are required for FcαR (CD89) trafficking to MHC class II compartments and FcαR-mediated antigen presentation. Traffic. 2004 5 : 577 594.
28. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983 11 : 1475 1489.
29. Carter CA. Protein kinase C as a drug target: implications for drug or diet prevention and treatment of cancer. Curr Drug Targets. 2000 1 : 163 183.
30. Chakraborti S, Michael JR, Chakraborti T. Role of an aprotinin-sensitive protease in protein kinase C α-mediated activation of cytosolic phospholipase A2 by calcium ionophore (A23187) in pulmonary endothelium. Cell Signal. 2004 16 : 751 762.
31. Gwak J, Cho M, Gong SJ, et al. Protein-kinase-C-mediated β-catenin phosphorylation negatively regulates the Wnt/β-catenin pathway. J Cell Sci. 2006 119 : 4702 4709.
32. Amit S, Hatzubai A, Birman Y, et al. Axin-mediated CKI phosphorylation of β-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev. 2002 16 : 1066 1076.
33. Hart M, Concordet JP, Lassot I, et al. The F-box protein β-TrCP associates with phosphorylated β -catenin and regulates its activity in the cell. Curr Biol. 1999 9 : 207 210.
34. Verma UN, Surabhi RM, Schmaltieg A, et al. Small interfering RNAs directed against β-catenin inhibit the in vitro and in vivo growth of colon cancer cells. Clin Cancer Res. 2003 9 : 1291 1300.
35. Polakis P. The oncogenic activation of β-catenin. Curr Opin Genet Dev. 1999 9 : 15 21.
36. Verstovsek G, Byrd A, Frey MR, et al. Colonocyte differentiation is associated with increased expression and altered distribution of protein kinase C isozymes. Gastroenterology. 1998 115 : 75 85.
37. Hao XP, Pretlow TG, Rao JS, et al. β-catenin expression is altered in human colonic aberrant crypt foci. Cancer Res. 2001 61 : 8085 8088.
38. Wade M, Wahl GM. c-Myc, genome instability, and tumorigenesis: the devil is in the details. Curr Top Microbiol Immunol. 2006 302 : 169 203.
39. Liu J, Stevens J, Rote CA, et al. Siah-1 mediates a novel β-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol Cell. 2001 7 : 927 936.
40. Orford K, Crockett C, Jensen JP, et al. Serine phosphorylation-regulated ubiquitination and degradation of β-catenin. J Biol Chem. 1997 272 : 24735 24738.
41. Marinez J, Vogler O, Casas J, et al. Membrane structure modulation, protein kinase Cα activation, and anticancer activity of minerval. Mol Pharmacol. 2005 67 : 531 539.